Back to top
more

22nd Century Group (XXII)

(Delayed Data from NSDQ)

$1.68 USD

1.68
81,573

+0.03 (1.82%)

Updated May 7, 2024 04:00 PM ET

After-Market: $1.68 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (95 out of 251)

Industry: Tobacco

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for XXII

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

22nd Century Group, Inc [XXII]

Reports for Purchase

Showing records 101 - 120 ( 134 total )

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 101

04/20/2021

Company Report

Pages: 9

WSJ Reports Biden Administration and FDA Considering Low-Nicotine Mandate

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 102

04/15/2021

Company Report

Pages: 8

BUY: Expect Multiple Catalysts this Year

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 103

04/13/2021

Company Report

Pages: 8

BUY: Expect Multiple Catalysts this Year-INITIATION REPORT

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 104

03/12/2021

Company Report

Pages: 11

Expect Multiple Catalysts this Year. Reiterate Buy.

Provider: Bradley Woods & Co., Ltd.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 105

03/09/2021

Company Report

Pages: 10

Q4 Preview

Provider: Bradley Woods & Co., Ltd.

Analyst: MCILREE J

Price: 25.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 106

02/22/2021

Company Report

Pages: 10

We reiterate our Buy recommendation on 22nd Century and raise our price target to $7.00.

Provider: Bradley Woods & Co., Ltd.

Analyst: MCILREE J

Price: 25.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 107

01/26/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for XXII

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 108

11/18/2020

Company Report

Pages: 10

Insider Buying.

Provider: Bradley Woods & Co., Ltd.

Analyst: MCILREE J

Price: 25.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 109

11/06/2020

Company Report

Pages: 11

Confidence in MRTP Approval

Provider: Bradley Woods & Co., Ltd.

Analyst: MCILREE J

Price: 25.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 110

09/28/2020

Company Report

Pages: 7

Focus on VLN, Hemp/Cannabis. 3rd Franchise to be Announced.

Provider: BRADLEY WOODS & CO., LTD.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 111

09/09/2020

Company Report

Pages: 7

New Management Hones Strategy

Provider: BRADLEY WOODS & CO., LTD.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 112

08/10/2020

Company Report

Pages: 8

Q2 Results and Outlook

Provider: BRADLEY WOODS & CO., LTD.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 113

08/04/2020

Company Report

Pages: 7

Q2 EPS Preview

Provider: BRADLEY WOODS & CO., LTD.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 114

08/04/2020

Company Report

Pages: 7

Q2 EPS Preview

Provider: BRADLEY WOODS & CO., LTD.

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 115

07/20/2020

Company Report

Pages: 21

Plant Biotechnology for Tobacco and Hemp

Provider: BRADLEY WOODS & CO., LTD.

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Tobacco

Record: 116

12/04/2019

Daily Note

Pages: 2

MORNING NOTE

Provider: M Partners, Inc.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Medical - Biomedical and Genetics

Record: 117

05/30/2018

Industry Report

Pages: 127

Microcaps Outperforming as Major Microcap Conference Approaches

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: SINE B

Price: 150.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Medical - Biomedical and Genetics

Record: 118

06/30/2012

Company Report

Pages: 3

We are terminating coverage of 22nd Century Group due to the departure from the firm of analyst

Provider: RODMAN & RENSHAW, CO.

Price: 10.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Medical - Biomedical and Genetics

Record: 119

04/02/2012

Industry Report

Pages: 4

MONTHLY PORTFOLIO UPDATE

Provider: RODMAN & RENSHAW, CO.

Analyst: PIROS E

Price: 10.00

Research Provided by a Third Party

Company: 22nd Century Group, Inc

Industry: Medical - Biomedical and Genetics

Record: 120

12/27/2011

Company Report

Pages: 6

Preliminary Results are Negative

Provider: RODMAN & RENSHAW, CO.

Analyst: PIROS E

Price: 25.00

Research Provided by a Third Party